Form D · Biotechnology
OMNILYTICS INC
Sandy, UT · CIK 0001273418
Offering snapshot reported Jul 9, 2013 · SEC filing
- Reported sold
- $200K Offering amount: $400K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jun 27, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 9, 2013 | Initial | $200,000 | No comparison | 1 | SEC filing |
| Dec 2, 2010 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Jan 30, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 29, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-199271
Source: Form D, filed Jul 9, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey O. Collett | Director, Executive |
| O. Jeffrey Collett | Director |
| Justin Clark Reber | Director, Executive |
| Julie D. Reber | Director |
| Clark L. Reber | Director |
| Alan K. Walbeck | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9100 S. 500 West
Sandy, UT, 84070
Sandy, UT, 84070